Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Rang in Aktien #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Aktienkurs
$0.069
Zuletzt synchronisiert: 2024-07-22
Marktkapitalisierung
$2.06M
Veränderung (1 Tag)
-1.43%
Veränderung (1 Jahr)
0.00%
Land
US
Handel DermTech, Inc. (DMTK)

Kategorie

EPS für DermTech, Inc. (DMTK)
EPS zum March 2024 TTM: $-2.70
Laut den aktuellen Finanzberichten und dem Aktienkurs von DermTech, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $-2.70. Am Ende des Jahres 2022 betrug das EPS $-3.88 eine Steigerung gegenüber dem EPS von 2021, das $-2.71 betrug.
EPS-Verlauf von DermTech, Inc. von 2012 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-2.70 -12.62%
2023 $-3.09 -20.36%
2022 $-3.88 43.17%
2021 $-2.71 32.20%
2020 $-2.05 -34.50%
2019 $-3.13 -969.44%
2018 $0.36 0.00%
2017 0.00 -100.00%
2013 $-1.10 69.23%
2012 $-0.65 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$18.62 -789.63%
US
$5.65 -309.26%
US
- -
CN
$-1.36 -49.63%
US
$14.24 -627.41%
US